Editorial policy

Sources we lead with

• · NICE technology appraisals (TA1026 for tirzepatide; relevant guidelines for related medications)
• · NHS England commissioning guidance and ICB statements
• · MHRA enforcement notices, drug-safety bulletins, and Yellow Card data
• · Patient Information Leaflets (PILs) from Eli Lilly (Mounjaro) and Novo Nordisk (Wegovy, Ozempic)
• · British National Formulary (BNF) for prescribing reference
• · Peer-reviewed clinical trial publications (SURMOUNT, STEP, SELECT)
• · The Pharmaceutical Journal, Health Foundation, BHF, Diabetes UK

Sources we use carefully

• · UK private clinic and pharmacy materials (we cite for pricing and policy, not clinical claims)
• · International sources (US FDA, European EMA) where they pre-date UK guidance
• · Peer review with caveats

Sources we do not use

• · Reddit, Mumsnet, and other unverified user forums for clinical claims
• · Brand blogs as the primary source for clinical claims
• · Influencer or anecdotal content
• · US bodybuilding-forum dosing protocols
• · Compounded or grey-import GLP-1 sources

No personal medical advice

PeptideClear does not publish dose-specific scenarios, individual symptom-triage runbooks, or content that assumes the role of a clinician. Editorial framing is comparison, encyclopedia, and commentary. Where readers need clinical decisions (eligibility, dose changes, side-effect management, switching), the page directs to a UK clinic or pharmacy partner whose prescriber takes that role.

No before/after imagery

We do not publish before/after weight-loss photos. The Advertising Standards Authority (ASA) treats them as misleading on POM advertising for GLP-1 medication. We agree.

No specific medication recommendations

We compare licensed routes (NHS, private clinic, online pharmacy). We summarise typical clinical practice. We do not recommend a specific medication, dose, or product to a specific person. Your prescriber does that, after a consultation.

Refresh cadence

Category and product comparison pages are refreshed when retailers, clinics, or regulatory guidance materially change. NICE, MHRA, NHS, and ASA notices trigger an immediate review of any affected page.

Corrections

Errors are corrected within 5 working days of being notified. Material corrections add a dated correction note to the page footer. Email [email protected].